Replies to post #141704 on PharmaCyte Biotech Inc (PMCB)

[DragonBear]

For a listing on the Nasdaq a company needs a 3 dollar minimum bid price

Try $4 instead. PMCB is skating on thin ice for $3, and about $1M shy of the net tangible asset requirement. For Kenny to uplist, the hilarious part is he would need to crank up another round of stock dilution first. So as to meet the net tangible asset requirement. Then at least a R/S of 1:300. Followed by what happens when a Microcrap performs a large R/S - the PPS fades quickly, since retail can't support it at $4, much less at 0.02 recently. All before Kenny has a chance to enact an up listing.

IF it ever made it to the Nasdaq then Kenny would have another problem. The PPS fades since it would still have no Tute support. How would he sell off blocks from the S3? What 3rd party would buy, without a mega discount up front? Where the Nasdaq would kick it back down to the OTC 6 months after it broke $1 going down.

Kenny's best move (for him) is to just keep on diluting away up to 50B shares. Throw in a R/S of 1:10 along the way to make it less ugly. Business as usual.